Indicators of cognitive impairment of varying severity in the acute period of ischemic stroke

To assess phenotype and identify biomarkers of cognitive impairment (CI) of varying severity in patients in the acute period of ischemic stroke (IS) based on the analysis of clinical and paraclinical indicators.